AstraZeneca Research This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Leukocytoclastic Vasculitis with Ischemic Colitis Following COVID-19 AstraZeneca Vaccine
Ann Dermatol. 2023 Nov;35(Suppl 2):S342-S344. doi: 10.5021/ad.21.157.NO ABSTRACTPMID:38061737 | DOI:10.5021/ad.21.157 (Source: Annals of Dermatology)
Source: Annals of Dermatology - December 7, 2023 Category: Dermatology Authors: So Yeon Yun Jin Young Choi Dong Soo Yu Young Bok Lee Source Type: research

A Generalized Lichen Planus Following COVID-19 Vaccination: A Case Report
Ann Dermatol. 2023 Nov;35(Suppl 2):S260-S264. doi: 10.5021/ad.22.026.ABSTRACTAs part of the efforts to overcome the ongoing coronavirus disease 2019 (COVID-19) pandemic, mass vaccination programs against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been initiated. Since then, an increasing number of cutaneous adverse events associated with the COVID-19 vaccines have been reported. Lichen planus (LP) is a rare inflammatory mucocutaneous disease with various clinical presentations, although uncommon, occurring following vaccination. There have been several cases of LP reported following COVID-19 vacc...
Source: Annals of Dermatology - December 7, 2023 Category: Dermatology Authors: Jee Yun Doh Ji Hyun Lee Source Type: research

mRNA vaccines may make unintended proteins, but there ’s no evidence of harm
Even after the billions of doses given during the pandemic, messenger RNA (mRNA) vaccines still hold surprises. A study out today reveals they may unexpectedly prompt cells to produce small amounts of unintended proteins. There is no evidence that these mistakes compromise the safety of the COVID-19 vaccines, which saved millions of lives, and the researchers have already proposed a fix that may help make future vaccines or drugs based on mRNAs safer and even more effective. Other scientists say there is nothing alarming about the new work, reported today in Nature , and agree that it could help im...
Source: Science of Aging Knowledge Environment - December 6, 2023 Category: Geriatrics Source Type: research

IgA Vasculitis following AstraZeneca/Oxford COVID-19, case report
We report a case of IgA vasculitis after AstraZeneca/Oxford COVID-19 vaccine. A 29-year-old healthy man who developed purpuric skin lesions one week after his second AstraZeneca/Oxford COVID-19 vaccine which complicated by glomerulonephritis and gastrointestinal involvement. Skin biopsy revealed fibrinoid necrosis and leukocytoclasia consistent with small vessel vasculitis. Due to the temporal association, AstraZeneca/Oxford COVID-19 vaccine-related IgA vasculitis would be the most likely explanation.PMID:38054690 | DOI:10.23750/abm.v94i6.12959 (Source: Acta Bio-Medica : Atenei Parmensis)
Source: Acta Bio-Medica : Atenei Parmensis - December 6, 2023 Category: General Medicine Authors: Nasser Alzoabi Jamal Alqahtani Bader Algamdi Nada Alghamdi Ayesha Ahmad Gaeda Alkaltham Tala Beidas Omar Alakloby Source Type: research